- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Ocular Therapeutix CEO Mattessich To Step Down, Dugel To Succeed | ||
| Mo | Elevance Health In Deal With Clayton And Dubilier & Rice To Advance Primary Care Delivery | ||
| Mo | Athira Pharma Appoints Javier San Martin As New Chief Medical Officer | ||
| Mo | Ultragenyx Reports Positive Interim Phase 1/2 Data With GTX-102 | ||
| Mo | FDA Places Clinical Hold On Neumora's Phase 1 Study Of NMRA-266; Stock Tanks In Pre-Market | ||
| Mo | Resideo To Buy Snap One In $1.4 Bln Deal; Snap One Stock Climbs In Pre-market | ||
| Mo | KBR To Serve As Global Licensor Of GeoLith's Li-Capt Technology | ||
| Mo | Getech Announces Joint Natural Hydrogen Exploration Agreement And Two Additional Contracts | ||
| Mo | Sirius Real Estate FY Rent-roll Up 8.2%; Sees FY Results In Line With Market View | ||
| Mo | Renold Now Projects FY24 Results To Be Materially Ahead Of Market Expectations | ||
| Mo | Encore Wire To Be Bought By Italy's Prysmian In $290/share Cash Deal | ||
| Mo | Nxera Pharma Announces Supply And Distribution Deal With Handok For PIVLAZ In South Korea | ||
| 12.04. | StubHub Set To Launch IPO In Summer: Reports | ||
| 12.04. | Argan Surges 23% After After Quarterly Revenue Jumps, Dividend Increased | ||
| 12.04. | Delek Logistics Announces Offering Of $200 Mln Of Addl. 8.625% Senior Notes Due 2029 | ||
| 12.04. | Portage Biotech Halts ADPORT-601 Trial Enrollment, To Explore Strategic Alternatives | ||
| 12.04. | Agenus Updates Phase 1 Data Of BOT/BAL Therapy In MSS Metastatic Colorectal Cancer | ||
| 12.04. | Bank7 Corp. Q1 Net Income Rises | ||
| 12.04. | Wells Fargo Q1 Profit Down, Revenues Rise; Stock Dips In Pre-market | ||
| 12.04. | MTY Food Q1 Net Income Declines | ||
| 12.04. | R&Q Insurance To Realise Significant Pre-tax Loss In FY | ||
| 12.04. | Provident Financial Services - Lakeland Bancorp Deal Receives Federal Reserve Board Approval | ||
| 12.04. | UL Solutions Announces Pricing Of IPO Of 33.80 Mln Shares Of Class A Common Stock At $28.00/shr | ||
| 12.04. | Nurix Therapeutics Announces $125 Mln Public Stock Offering; Stock Down In After-hours | ||
| 12.04. | Nyxoah Appoints Maurits Boon As Chief Medical Officer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
